Report cover image

In Vitro Diagnostics Market (Technology Type: Point-of-care, Molecular Diagnostics, Immunoassays, Clinical Chemistry, Whole Blood Glucose Monitoring, Hematology, Clinical Microbiology, Coagulation & Hemostasis, and Others; Application: Drug Testing, Infec

Publisher Transparency Market Research Pvt. Ltd.
Published Feb 26, 2022
Length 222 Pages
SKU # TNPR17067625

Description

In Vitro Diagnostics Market (Technology Type: Point-of-care, Molecular Diagnostics, Immunoassays, Clinical Chemistry, Whole Blood Glucose Monitoring, Hematology, Clinical Microbiology, Coagulation & Hemostasis, and Others; Application: Drug Testing, Infectious Diseases, Oncology, Metabolic Diseases, Autoimmune Diseases, and Others; and End-user: Diagnostic Laboratories, Hospitals, Academic & Research Centers, Home Care, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

In Vitro Diagnostics Market – Scope of Report
TMR’s report on the global in vitro diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global in vitro diagnostics market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in vitro diagnostics market from 2021 to 2028.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the in vitro diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global in vitro diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global in vitro diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in vitro diagnostics market.

The report delves into the competition landscape of the global in vitro diagnostics market. Key players operating in the global in vitro diagnostics market have been identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global in vitro diagnostics market profiled in this report.

Key Questions Answered in Global In Vitro Diagnostics Market Report
What will be the revenue generated in the global in vitro diagnostics market across all geographies during the forecast period?
What are key trends in the in vitro diagnostics market?
What are major drivers, restraints, and opportunities in the market?
Which region is set to expand at the maximum CAGR during the forecast period?
Which segment of the global in vitro diagnostics market will generate the maximum revenue globally by 2028?
Which segment will expand at the maximum CAGR during the forecast period?
In Vitro Diagnostics Market – Research Objectives and Research Approach
The comprehensive report on the global in vitro diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global in vitro diagnostics market in terms of technology type, application, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2028 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in vitro diagnostics market.

Companies Mentioned

Competition Matrix
F. Hoffmann-La Roche Ltd.
Danaher
Siemens Healthineers
bioMérieux SA
Abbott
Diasorin
Meridian Bioscience, Inc.
Ortho-Clinical Diagnostics, Inc.
Thermo Fisher Scientific, Inc.
Sysmex Corporation
Other Prominent Players

Table of Contents

222 Pages
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global In Vitro Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Application Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global In Vitro Diagnostics Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Key Mergers and Acquisition
5.2. Key Success Factor for Top 3 Players
5.3. Regulatory Scenario
5.4. Technology Assessment
6. Global In Vitro Diagnostics Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Application, 2017–2028
6.3.1. Drug Testing
6.3.2. Infectious Diseases
6.3.3. Oncology
6.3.4. Metabolic Diseases
6.3.5. Autoimmune Diseases
6.3.6. Others
6.4. Market Attractiveness Analysis, by Application
7. Global In Vitro Diagnostics Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value & Volume Forecast, by End-user, 2017–2028
7.3.1. Diagnostic Laboratories
7.3.2. Hospitals
7.3.3. Academic & Research Centers
7.3.4. Home Care
7.3.5. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global In Vitro Diagnostics Market Analysis and Forecast, by Technology Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value & Volume Forecast, by Technology Type, 2017–2028
8.3.1. Point-of-care
8.3.2. Molecular Diagnostics
8.3.3. Immunoassays
8.3.4. Clinical Chemistry
8.3.5. Whole Blood Glucose Monitoring
8.3.6. Hematology
8.3.7. Clinical Microbiology
8.3.8. Coagulation & Hemostasis
8.3.9. Others
8.4. Market Attractiveness Analysis, by Technology Type
9. Global In Vitro Diagnostics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value & Volume Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America In Vitro Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Application, 2017–2028
10.2.1. Drug Testing
10.2.2. Infectious Diseases
10.2.3. Oncology
10.2.4. Metabolic Diseases
10.2.5. Autoimmune Diseases
10.2.6. Others
10.3. Market Value & Volume Forecast, by End-user, 2017–2028
10.3.1. Diagnostic Laboratories
10.3.2. Hospitals
10.3.3. Academic & Research Centers
10.3.4. Home Care
10.3.5. Others
10.4. Market Value & Volume Forecast, by Technology Type, 2017–2028
10.4.1. Point-of-care
10.4.2. Molecular Diagnostics
10.4.3. Immunoassays
10.4.4. Clinical Chemistry
10.4.5. Whole Blood Glucose Monitoring
10.4.6. Hematology
10.4.7. Clinical Microbiology
10.4.8. Coagulation & Hemostasis
10.4.9. Others
10.5. Market Value & Volume Forecast, by Country, 2017–2028
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Application
10.6.2. By End-user
10.6.3. By Technology Type
10.6.4. By Country
11. Europe In Vitro Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Application, 2017–2028
11.2.1. Drug Testing
11.2.2. Infectious Diseases
11.2.3. Oncology
11.2.4. Metabolic Diseases
11.2.5. Autoimmune Diseases
11.2.6. Others
11.3. Market Value & Volume Forecast, by End-user, 2017–2028
11.3.1. Diagnostic Laboratories
11.3.2. Hospitals
11.3.3. Academic & Research Centers
11.3.4. Home Care
11.3.5. Others
11.4. Market Value & Volume Forecast, by Technology Type, 2017–2028
11.4.1. Point-of-care
11.4.2. Molecular Diagnostics
11.4.3. Immunoassays
11.4.4. Clinical Chemistry
11.4.5. Whole Blood Glucose Monitoring
11.4.6. Hematology
11.4.7. Clinical Microbiology
11.4.8. Coagulation & Hemostasis
11.4.9. Others
11.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Application
11.6.2. By End-user
11.6.3. By Technology Type
11.6.4. By Country/Sub-region
12. Asia Pacific In Vitro Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Application, 2017–2028
12.2.1. Drug Testing
12.2.2. Infectious Diseases
12.2.3. Oncology
12.2.4. Metabolic Diseases
12.2.5. Autoimmune Diseases
12.2.6. Others
12.3. Market Value & Volume Forecast, by End-user, 2017–2028
12.3.1. Diagnostic Laboratories
12.3.2. Hospitals
12.3.3. Academic & Research Centers
12.3.4. Home Care
12.3.5. Others
12.4. Market Value & Volume Forecast, by Technology Type, 2017–2028
12.4.1. Point-of-care
12.4.2. Molecular Diagnostics
12.4.3. Immunoassays
12.4.4. Clinical Chemistry
12.4.5. Whole Blood Glucose Monitoring
12.4.6. Hematology
12.4.7. Clinical Microbiology
12.4.8. Coagulation & Hemostasis
12.4.9. Others
12.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Application
12.6.2. By End-user
12.6.3. By Technology Type
12.6.4. By Country/Sub-region
13. Latin America In Vitro Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Application, 2017–2028
13.2.1. Drug Testing
13.2.2. Infectious Diseases
13.2.3. Oncology
13.2.4. Metabolic Diseases
13.2.5. Autoimmune Diseases
13.2.6. Others
13.3. Market Value & Volume Forecast, by End-user, 2017–2028
13.3.1. Diagnostic Laboratories
13.3.2. Hospitals
13.3.3. Academic & Research Centers
13.3.4. Home Care
13.3.5. Others
13.4. Market Value & Volume Forecast, by Technology Type, 2017–2028
13.4.1. Point-of-care
13.4.2. Molecular Diagnostics
13.4.3. Immunoassays
13.4.4. Clinical Chemistry
13.4.5. Whole Blood Glucose Monitoring
13.4.6. Hematology
13.4.7. Clinical Microbiology
13.4.8. Coagulation & Hemostasis
13.4.9. Others
13.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Application
13.6.2. By End-user
13.6.3. By Technology Type
13.6.4. By Country/Sub-region
14. Middle East & Africa In Vitro Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value & Volume Forecast, by Application, 2017–2028
14.2.1. Drug Testing
14.2.2. Infectious Diseases
14.2.3. Oncology
14.2.4. Metabolic Diseases
14.2.5. Autoimmune Diseases
14.2.6. Others
14.3. Market Value & Volume Forecast, by End-user, 2017–2028
14.3.1. Diagnostic Laboratories
14.3.2. Hospitals
14.3.3. Academic & Research Centers
14.3.4. Home Care
14.3.5. Others
14.4. Market Value & Volume Forecast, by Technology Type, 2017–2028
14.4.1. Point-of-care
14.4.2. Molecular Diagnostics
14.4.3. Immunoassays
14.4.4. Clinical Chemistry
14.4.5. Whole Blood Glucose Monitoring
14.4.6. Hematology
14.4.7. Clinical Microbiology
14.4.8. Coagulation & Hemostasis
14.4.9. Others
14.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Application
14.6.2. By End-user
14.6.3. By Technology Type
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Market Footprint Analysis
15.3.1. By Region
15.3.2. By Application Type
15.4. Competitive Business Strategies
15.5. Company Profiles
15.5.1. Competition Matrix
15.5.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.1.2. Product Portfolio
15.5.1.3. SWOT Analysis
15.5.1.4. Strategic Overview
15.5.2. F. Hoffmann-La Roche Ltd.
15.5.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.2.2. Product Portfolio
15.5.2.3. SWOT Analysis
15.5.2.4. Strategic Overview
15.5.3. Danaher
15.5.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.3.2. Product Portfolio
15.5.3.3. SWOT Analysis
15.5.3.4. Strategic Overview
15.5.4. Siemens Healthineers
15.5.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.4.2. Product Portfolio
15.5.4.3. SWOT Analysis
15.5.4.4. Strategic Overview
15.5.5. bioMérieux SA
15.5.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.5.2. Product Portfolio
15.5.5.3. SWOT Analysis
15.5.5.4. Strategic Overview
15.5.6. Abbott
15.5.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.6.2. Product Portfolio
15.5.6.3. SWOT Analysis
15.5.6.4. Strategic Overview
15.5.7. Diasorin
15.5.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.7.2. Product Portfolio
15.5.7.3. SWOT Analysis
15.5.7.4. Strategic Overview
15.5.8. Meridian Bioscience, Inc.
15.5.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.8.2. Product Portfolio
15.5.8.3. SWOT Analysis
15.5.8.4. Strategic Overview
15.5.9. Ortho-Clinical Diagnostics, Inc.
15.5.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.9.2. Product Portfolio
15.5.9.3. SWOT Analysis
15.5.9.4. Strategic Overview
15.5.10. Thermo Fisher Scientific, Inc.
15.5.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.10.2. Product Portfolio
15.5.10.3. SWOT Analysis
15.5.10.4. Strategic Overview
15.5.11. Sysmex Corporation
15.5.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.11.2. Product Portfolio
15.5.11.3. SWOT Analysis
15.5.11.4. Strategic Overview
15.5.12. Other Prominent Players
15.5.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.12.2. Product Portfolio
15.5.12.3. SWOT Analysis
15.5.12.4. Strategic Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us